The National Health Council in the News
Media Relations
NHC Fact Sheet (PDF)
Media inquiries should be directed to:
Nancy Hughes
E-mail: nhughes@nhcouncil.org
Phone: 202-973-0550
05-20-13— NHC urges FDA to discuss Benefit/Risk framework. (Subscription required)— Inside Health
05-08-13— NHC Executive Vice President and COO Marc Boutin discusses PCORI and the importance of patient engagement— Genetic Engineering & Biotechnology News
03-25-13— NHC Executive Vice President and COO Marc Boutin discusses the FDA's draft benefit-risk framework (Subscription required) — BioCentury
03-21-13— NHC Chief Executive Officer Myrl Weinberg issues a statement on the appointment of the Patient-Centered Outcomes Research Institute's new Chief Officer for Engagement — PCORI News Release
03-18-13— Boutin comments on report from the Department of Health and Human Services Office of Inspector General highlighting inefficiencies in the FDA's drug Risk Evaluation and Mitigation Strategies (REMS) - Subscription required — Inside Health
03-17-13— NHC CEO Myrl Weinberg interviewed about the MODDERN Cures Act to advance the discovery of new treatments and new diagnostics— BioCentury TV
03-13-13— NHC Executive Vice President and COO Marc Boutin offers the patient perspective on the FDA's draft report for creating a benefit-risk framework. (Subscription required)— Law360
03-08-13— NHC Executive Vice President and COO Marc Boutin offers the patient perspective on the FDA's draft report for creating a benefit-risk framework. (Subscription required)— FDA Week
02-21-13— NHC Executive Vice President Marc Boutin on the release of the final rule for essential health benefits provided under the Affordable Care Act (Subscription required)— Wall Street Journal
02-01-13— NHC President Myrl Weinberg on the need for a process to evaluate the usability of research findings — American Journal of Pharmacy Benefits
01-28-13— NHC Executive Vice President and COO Marc Boutin discusses the concept of "limited-use pathways" for medications. (Subscription required to read)— BioCentury
12-21-12— Commentary by NHC President Myrl Weinberg on essential health benefits — Huffington Post
11-20-12— Article on the essential health benefits proposed regulation as indicated by the Affordable Care Act. Includes mention of the National Health Council — Modern Healthcare
11-20-12— Article on essential health benefits proposed rule. Includes mention of the National Health Council (Subscription Required)— Inside Health Policy
11-12-12— BioCentury recently featured NHC Executive Vice President and COO Marc Boutin discussing the ramifications of the November 2012 elections on the continued implementation of the Affordable Care Act and sequestrations on its weekly television program and in it' trade publication.
11-01-12— NHC EVP and COO Marc Boutin spoke at the October 11, 2012, Health Affairs briefing on "Current Challenges in Comparative Effectiveness Research." After the briefing, Boutin participated in three short interviews with NHC member the National Pharmaceutical Council (NPC).
10-19-12— Comments by Boutin on essential health benefits as directed by the Affordable Care Act (Subscription Required)— Inside Health Policy
10-19-12— Comments by NHC Director of Government Affairs Eric Gascho on the the FDA's patient-focused drug development disease list (Subscription Required)— Inside Health Policy
10-01-12— Article by Boutin on importance of ensuring comparative effectiveness research is done right by establishing usefulness criteria, developing a means of evaluating research findings against those criteria, and engaging both patients and the organizations that represent them throughout the research process— Health Affairs
10-01-12— Article on HR 6446, a bill introduced in the House of Representatives, aimed to create incentives for innovative diagnostics by improving the process for determining Medicare payment rates for new tests. Includes a mention of the National Health Council (Subscription Required)— GenomeWeb
